BROTIZOLAM TEVA 0.25 MG

Country: Israel

Language: English

Source: Ministry of Health

Buy It Now

Active ingredient:

BROTIZOLAM

Available from:

TEVA ISRAEL LTD

ATC code:

N05CD09

Pharmaceutical form:

TABLETS

Composition:

BROTIZOLAM 0.25 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutic area:

BROTIZOLAM

Therapeutic indications:

For the treatment of insomnia.

Authorization date:

2015-09-30

Patient Information leaflet

                                PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor’s
prescription only
Brotizolam Teva 0.25 mg
Tablets
Composition:
Each tablet contains:
Brotizolam 0.25 mg
For information regarding inactive ingredients
and allergens, see section 2 “Important
information about some of the ingredients
of the medicine” and section 6 “Additional
information”.
Read the entire leaflet carefully before
using the medicine. This leaflet contains
concise information about the medicine. If
you have additional questions, refer to the
doctor or the pharmacist.
This medicine has been prescribed for
you. Do not pass it on to others under any
circumstances. It may harm them even if it
seems to you that their medical condition
is similar.
Introduction
This medicine belongs to the benzodiazepines
group, which has special characteristics that
require extra care during use.
It is highly important to be under close
medical supervision when taking this
medicine. When taking this medicine, be
sure to refer to the doctor after 2 weeks,
since the treatment is only intended for
short time periods.
Prolonged use of this medicine may cause
the effect of the medicine to decrease.
Prolonged use may cause a severe effect
of dependence, which will make it difficult
for the patient to stop taking the medicine.
Therefore, you should stop taking the
medicine gradually, according to the doctor’s
instructions.
Uncontrolled discontinuation of the treatment
may be accompanied by withdrawal effects
such as: stress, nervousness, confusion,
tremor, insomnia, abdominal pain, vomiting,
nausea, sweating, spasms, cramps and
muscle pain.
Prolonged use of this medicine may
sometimes cause changes in behavioral
patterns and obsessive thoughts.
Especially in the elderly: care should be
taken when walking, since the medicine
impairs alertness and sometimes the
coordination of body movements, which
may lead to tripping or falling down.
Taking this medicine together with opioid
medicines, w
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Arabic 26-10-2023
Patient Information leaflet Patient Information leaflet Hebrew 26-10-2023

Search alerts related to this product